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Endothelial cells, when activated by endotoxin or IL-1, support a procoagulant 
generating system oriented at the surface membrane (1-5). Endothelial cells also 
play an important role in fibrinolysis (6) by secreting plasminogen activators and 
a rapidly acting inhibitor of plasminogen activator (7-9). The modulation of the 
synthesis  of these  several  activities in  different  pathophysiologic  circumstances 
may significantly influence the anticoagulant or procoagulant role of the vascular 
endothelium. Fibrinolytic inhibitors directed against plasminogen activators have 
been reported in several cell types, including  bovine aortic endothelial  cells (8), 
umbilical  venous  endothelium  (10),  human  platelets  (11),  mouse  macrophages 
(12),  and  rat  hepatoma  cells  (13).  In  this  study  we  report  the  induction  of 
plasminogen  activator  inhibitor  (PAl)  synthesis  by  IL-1  stimulation  of human 
cultured endothelial  cells. 
Materials and  Methods 
Materials.  rIL-1 (pI 7.0 or "beta" form) with expression from amino acid  112 to 269 
was obtained as described previously (14).  This rIL-1  was homogenous on  SDS-PAGE 
and  contained  60  pg  of endotoxin  per  mg protein.  Recombinant  tissue  plasminogen 
activator (TPA) was kindly provided by Genentech  Inc. (San Francisco, CA).  Urokinase 
(UK) was a girl from The Sterling Winthrop Research Institute (Rensselaer, NY). 
Cell Culture.  Early passage (P2-Ps) human umbilical vein endothelial cells (HUVEC) 
were grown to confluency on gelatin-coated 24-w311  tissue culture plates as previously 
described  (15-16).  The cells  were plated at a  density of ~5  ×  104 cells/well,  reached 
confluency by 48-72 h, and were used within  3-5 days of plating. The culture medium 
consisted of Medium  199 containing 50 U/ml penicillin-50 ~ag/ml streptomycin, 2.5 ug/ 
ml fungizone,  2.0  mM L-glutamine,  20 #g/ml endothelial  cell growth  factor, 90 #g/ml 
porcine intestinal  mucosa heparin  (170  USP  U/rag),  and  20%  (vol/vol) pooled human 
seruln. 
For cell passage, monolayers on 25 or 75 cm  ~ flasks were washed with Hepes-buffered 
saline  (HBS;  11  mM  N-2-hydroxyethylpiperazine-N'-2-ethane  sulfonic  acid,  137  mM 
NaCI,  4  mM  KCL,  11  mM  glucose,  pH  7.4)  and  then  incubated  for  5  min  in  HBS 
containing  0.05%  Type I  collagenase,  0.01%  EDTA,  and  0.25%  BSA at  37°C.  After 
addition of an equal volume of human serum containing medium, cells were washed once, 
resuspended, and replated. 
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In  each  experiment,  endothelial  cells  were  used  at  confluency, at  which  time  they 
exhibited typical  polygonal, cobblestone appearance.  Each  1.7-cm  well contained ~2  × 
105 cells. The monolayers were washed twice with sterile Medium 199 containing 5 mg/ml 
BSA (essentially free of  fatty acid and globulin) (M 199/BSA) at 37 °  C. For I L- 1 stimulation, 
we added various concentrations of rIL-1 (in M 199/BSA) and incubated the cells at 37 °C 
in  a  humidified  atmosphere  containing  6%  CO2  for  various  periods  of time.  After 
incubation, the postculture medium was collected, made 0.01% with Triton X-100, and 
for some experiments, stored at -70°C until assayed. 
To  examine  the  effect  of cycloheximide on  the  production  of PAI,  cultures  were 
incubated for 30 rain  with  0.1  mM cycloheximide (Sigma  Chemical Co., St. Louis, MO) 
in M 199/BSA or M 199/BSA alone. The cells were then washed three times with warm 
M199/BSA and incubated for an additional  18 h with M199/BSA with or without rIL-1 
(5.32 ng/ml). Postculture medium was then harvested as described above. 
Quantitative PAl Assay.  ~25I-fibrin plates were prepared by the method of Unkeless et 
al. (17), as previously described (18). We added 200 ul J2~I-conjugated bovine fibrinogen 
to 24-well  tissue  culture plates (100 ttg/ml,  3-5 x  105 CPM/well).  The wells were then 
air-dried at 37 °C, clotted with  thrombin (0.04 ug/ml), and extensively washed.  Immedi- 
ately before use they were washed three times,  incubated with lys-plasminogen (10 ug/ml) 
at 20°C for 30 min, then washed again. Endothelial cell postculture medium (diluted in 
preculture medium) was incubated with purified TPA (0.5  U/ml) at 37°C for 1 h in the 
presence of 0.01% Triton X-100 and then added in duplicate to wells in a volume of 0.2 
ml. At 10 rain  time intervals  10-#1 aliquots were removed and counted to quantify serial 
release of fibrin degradation products. The time to half maximum lysis ($50), which in this 
system  where  plasminogen  and  fibrin  concentrations  are  constant  is  a  reproducible 
measure of TPA activity, was then determined from the sigmoidal lysis curves. Residual 
TPA activity was then determined from standard curves relating $50 to TPA concentra- 
tion. Standard curves were obtained for each set of plates.  A unit of PAI was defined as 
the amount of inhibitor required to inhibit one unit of TPA in this assay, i.e.,  for each 
well [(total  TPA -  residual TPA) × dilution =PAI units/well/. 
TPA Antigen Levels.  TPA antigen levels in endothelial cell conditioned medium were 
determined by a double antibody sandwich ELISA using the Imunbind TPA kit. (Amer- 
ican Diagnostica Inc., Greenwich, CT). 
Reverse Fibrin  Autography.  Reverse  fibrin  autography was  performed  essentially  as 
described by Levin and Loskutoff (19).  SDS-PAGE was performed by the procedure of 
Laemmli  (20)  using  7.5  or  9.0%  resolving gels  and  3.9%  stacking  gels.  Mr  standards 
included  myosin (200,000),  /3-galactosidase  (116,250),  phosphorylase B  (92,500),  BSA 
(66,200), OVA (45,000), carbonic anhydrase (31,000), soybean trypsin inhibitor (21,000), 
and  lysozyme (14,400).  After  soaking  for  90  min  in  2.5%  Triton  X-100,  gels  to  be 
analyzed were applied to the surface of a freshly formed fibrin agar gel containing (final 
concentrations): agarose 1.25%, fibrinogen 1.74 mg/ml, plasminogen 25 #g/ml, thrombin 
0.25 U/ml, and TPA 10 U/ml. Each fibrin agar gel measured 5.5 x  10.5 cm and occupied 
a  volume  of 9.6  ml.  Incubated  gels  were  stained  with  amido  black  0.05%  in  40% 
ethanol/10% acetic acid, destained with 90% ethanol/5% acetic acid, photographed, and 
then analyzed. 
Demonstration of PAI-UK Complex Formation by SDS-PAGE Autoradiography.  10 #1 of 
~25I-UK (0.3  U;  5,000  cpm/U) was  incubated  for  30  min  at  37°C  with  either  30  ul 
MI99/BSA, postculture  medium  from  nonstimulated  endothelial  cells,  or postculture 
medium  from  IL-1- (5.3  ng/ml)  stimulated  cells.  Samples  were  then  incubated  with 
Cibacron Blue-Sepharose for 30 min at 37°C. The supernatants were then electropho- 
resed  under  nonreducing conditions,  as  described  above,  using  7.5%  acrylamide with 
prestained  molecular weight standards  (Bethesda  Research  Laboratories, Gaithersburg, 
MD). The gels were then dried and autoradiographs obtained. 
Results 
PAI activity was detectable at low levels in the conditioned medium obtained 
fi'om resting endothelial cell monolayers. After IL-1 stimulation, there was a  10- 
fold  increase  in  the  PAl  released  into  the  conditioned  medium  (Fig.  1).  This 
stimulatory effect of IL-1 was dose-dependent, with a minimal effect detected at NACHMAN  ET  AL.  BRIEF  DEFINITIVE  REPORT  1597 
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FIGURE  1.  Effect of IL-1  on the PAl content of conditioned medium from cultured endo- 
thelial cells. Confluent human endothelial cell monolayers were incubated at 37 ° in M 199/BSA 
for  18 h  with or without IL-1  (5.32 ng/ml). At the completion of the incubation period, the 
postcukure medium was collected, made 0.01% with Triton ×  100, centrifuged at  1,200 g  to 
remove cell debris, and assayed for PAl activity by preincubation with TPA (0.5 U  for 1 h at 
37 o) and measuring the residual TPA activity on ~25I-fibrin  plates containing plasminogen. (A) 
Post culture medium from nonstimulated cells. Mean =  0.125  U/ml +  0.042 (SEM). n  -- 4. 
(B) Postculture medium from IL-l-stimulated cells. Mean =  1.13  U/ml +  0.075 (SEM). n  = 
6. 
3-4  h  and  a  maximum  effect detected after  18  h  of IL-1  incubation.  IL-I- 
stimulated PAI release into the conditioned medium was dependent on endothe- 
lial cell protein synthesis. Preincubation of endothelial cell monolayers with 0.1 
mM cycloheximide for 30 min followed by 18 h of stimulation with IL-1 abolished 
the release of PAI into the conditioned medium. 
Plasminogen activator activity as assayed in the ~25I-fibrin plate system was not 
detected either  in resting  or in  IL-l-stimulated  monolayers. The TPA antigen 
level  in  IL-l-stimulated,  conditioned  medium  was  unchanged  compared  with 
medium obtained from resting cells (Fig. 2). This reflects the fact, as previously 
observed (10),  that  TPA  released  from  human  endothelial  cells is  complexed 
with PAI, which appears to be present in excess in the conditioned medium from 
these cells. 
The PAI synthesized by the IL-l-stimulated endothelial cells was equally active 
against both TPA and  urokinase,  and  was not inhibited  by DFP (10  mM) nor 
inactivated  by acid  exposure  (pH  3.0  for  1  h),  a  treatment  that  destroys the 
protease  inhibitors,  ~-2-antiplasmin  (21),  and  protease  nexin  (22).  By reverse 
fibrin autography, the PAI in conditioned medium was stable to SDS treatment 
and had an approximate molecular weight of 63,000 (Fig. 3). Incubation of 125I- 
UK with postculture medium from stimulated endothelial cells showed formation 
of a  radioactive  complex  of approximate  molecular  weight  110,000  (Fig.  4). 
Thus, this PAI is likely the same as that described by Loskutoff et al. (8). 1598  NACHMAN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIGURE  2.  Effect of IL-1  on  TPA  antigen  levels  of conditioned medium  from cultured 
endothelial cells.  Confluent human  endothelial cell monolayers were incubated at  37°C in 
MI99/BSA for 18 h with or without IL-I  (5.32 ng/ml). The postculture medium was made 
0.01% with Triton X-100, centrifuged at 1,200 g to remove cell debris, and assayed for TPA 
antigen  levels  using  a  sandwich  double  antibody  ELISA.  (A)  Postculture  medium  from 
nonstimulated cells. (B) Postculture medium from stimulated cells. Mean +  SEM. n =  6. 
FIGURE 3.  Identification of PAl by reverse fibrin autography. Detergent-treated postculture 
medium from (A) nonstimulated cells and (B)  IL-l-stimulated cells (5.32  ng/ml,  18  h) was 
concentrated fivefold using Centricon  10  filters (60  min;  1,000 g;  starting volume,  1 ml). 
Samples were run on a  7.5%  Laemmli slab gel, soaked in Triton X-100 (2.5%, 90 min), and 
applied to a  fibrin agar gel as described in Materials and Methods. The gel and the overlay 
were incubated in a moist chamber at 37°C for 4 h, stained, destained, then compared with 
Mr markers run in the same gel and stained with Coomassie blue. 
Discussion 
Recent studies have suggested that IL-1  stimulates endothelial cells  in vitro, 
leading to the biosynthesis and surface expression of a tissue factor like proco- 
agulant, as well  as surface adhesion molecules that mediate the attachment of 
polymorphonuclear leukocytes and monocytes (4, 23).  In addition, IL-1 infusion 
in  rabbits  has  been  shown  to  down  regulate the  protein  C-thrombomodulin 
anticoagulant pathway on endothelial cell surfaces (24). It therefore appears that 
IL-1, a potent mediator of inflammatory responses, has a  markedly prothrom- 
boric effect on endothelial cell function. The auto-regulatory effects of proco- 
agulant events occurring at the endothelial cell surface have been pointed out 
by Stern et al. (1). Thus endothelial cells produce IL-1 after exposure to thrombin 
(1),  and thrombin has been shown to lead to the induction of PAI  in cultured 
human endothelial cells (10). Our studies showing IL-1 induction of PAI synthesis 
and release by endothelial cells further emphasizes positive feedback modulation 
of procoagulant events at the endothelial cell  surface. Thrombin induction of NACHMAN  ET  AL.  BRIEF  DEFINITIVE REPORT  1599 
FTGURE 4.  Demonstration  of PAI-UK Complex  Formation.  SDS-PAGE autoradiogram  of 
12~I-UK (0.3 U; 5000 CPM/U) incubated for 30 rain at 37°C with either M 199/BSA (lane  I), 
postculture  medium  from nonstimulated  cells (lane  2),  or postculture  medium  from IL-I- 
stimulated cells (lane 3). The arrow indicates the 110,000 mol. weight complex. 
endothelial  cell  IL-1  can  lead  to  a  series  of prothrombotic  signals,  including 
synthesis of PAI, which further potentiates thrombosis in the immediate microen- 
vironment.  It may be  useful  to  regard  these  IL-l-induced  changes  as an  early 
manifestation of endothelial  cell injury. 
Summary 
Human  endothelial  cells  activated  with  IL-1  express  a  surface  membrane- 
oriented procoagulant generating system characterized by increased tissue factor 
synthesis and decreased thrombomodulin activity. We now report that IL-1 also 
stimulates  endothelial  cell  synthesis  of  plasminogen  activator  inhibitor.  This 
array of IL-l-induced activities shifts the balance at the endothelial  cell surface 
to  a  prothrombotic  influence  and  may  reflect  an  early  response  of the  blood 
vessel wall to injury. 
Received for publication  11 March  1986. 
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